- Home
- DGLY vs QLGN Comparison
DGLY vs QLGN Comparison
Compare DGLY & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- QLGN
- Stock Information
- Founded
- DGLY 2004
- QLGN 1996
- Country
- DGLY United States
- QLGN United States
- Employees
- DGLY N/A
- QLGN N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- QLGN Health Care
- Exchange
- DGLY Nasdaq
- QLGN Nasdaq
- Market Cap
- DGLY 3.2M
- QLGN 3.1M
- IPO Year
- DGLY N/A
- QLGN N/A
- Fundamental
- Price
- DGLY $1.96
- QLGN $2.29
- Analyst Decision
- DGLY
- QLGN
- Analyst Count
- DGLY 0
- QLGN 0
- Target Price
- DGLY N/A
- QLGN N/A
- AVG Volume (30 Days)
- DGLY 222.7K
- QLGN 209.6K
- Earning Date
- DGLY 08-18-2025
- QLGN 11-13-2025
- Dividend Yield
- DGLY N/A
- QLGN N/A
- EPS Growth
- DGLY N/A
- QLGN N/A
- EPS
- DGLY N/A
- QLGN N/A
- Revenue
- DGLY $18,612,519.00
- QLGN N/A
- Revenue This Year
- DGLY N/A
- QLGN N/A
- Revenue Next Year
- DGLY $7.38
- QLGN N/A
- P/E Ratio
- DGLY N/A
- QLGN N/A
- Revenue Growth
- DGLY N/A
- QLGN N/A
- 52 Week Low
- DGLY $1.66
- QLGN $1.61
- 52 Week High
- DGLY $119.00
- QLGN $10.45
- Technical
- Relative Strength Index (RSI)
- DGLY 49.76
- QLGN 66.93
- Support Level
- DGLY $1.77
- QLGN $1.95
- Resistance Level
- DGLY $2.06
- QLGN $3.05
- Average True Range (ATR)
- DGLY 0.16
- QLGN 0.19
- MACD
- DGLY 0.05
- QLGN 0.10
- Stochastic Oscillator
- DGLY 36.71
- QLGN 52.52
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.